NM_005903.7:c.-245+5111G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005903.7(SMAD5):c.-245+5111G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 152,196 control chromosomes in the GnomAD database, including 2,297 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.17 ( 2297 hom., cov: 32)
Consequence
SMAD5
NM_005903.7 intron
NM_005903.7 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.63
Publications
10 publications found
Genes affected
SMAD5 (HGNC:6771): (SMAD family member 5) The protein encoded by this gene is involved in the transforming growth factor beta signaling pathway that results in an inhibition of the proliferation of hematopoietic progenitor cells. The encoded protein is activated by bone morphogenetic proteins type 1 receptor kinase, and may be involved in cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.192 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.172 AC: 26177AN: 152078Hom.: 2298 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
26177
AN:
152078
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.172 AC: 26167AN: 152196Hom.: 2297 Cov.: 32 AF XY: 0.166 AC XY: 12319AN XY: 74384 show subpopulations
GnomAD4 genome
AF:
AC:
26167
AN:
152196
Hom.:
Cov.:
32
AF XY:
AC XY:
12319
AN XY:
74384
show subpopulations
African (AFR)
AF:
AC:
6990
AN:
41522
American (AMR)
AF:
AC:
2091
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
739
AN:
3468
East Asian (EAS)
AF:
AC:
500
AN:
5184
South Asian (SAS)
AF:
AC:
466
AN:
4826
European-Finnish (FIN)
AF:
AC:
1502
AN:
10588
Middle Eastern (MID)
AF:
AC:
57
AN:
294
European-Non Finnish (NFE)
AF:
AC:
13267
AN:
67998
Other (OTH)
AF:
AC:
424
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1135
2270
3404
4539
5674
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
378
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.